The nation of Zimbabwe has turned down a substantial US healthcare agreement worth $367m (272 million pounds) over five years over the United States' demand for confidential biological samples.
The decision became public following a government memo from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since stated that the US was seeking genetic material for scientific study and commercial gain but was unwilling to guarantee the benefits from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has called for more talks to secure a agreement agreeable to both sides so the nation's vital HIV programme can proceed.
Broader Implications
This development follows a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US following concerns were raised about the security of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
Based on statements, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided significant benefits for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.
"Effectively, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our citizens should a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks previously established via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This framework is designed to guarantee that when a country provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how subsequent co-operation could be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
Medical experts stated it acknowledged the official position, but urged that talks need to persist given that a large portion of the nation's Aids initiatives relied on external financing.
"Where specific concerns arise, such as those involving data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group said.
The situation underscores the continuing tensions between receiving vital foreign assistance and safeguarding local interests in an ever more interconnected world.